groupH
  • About Us
    • How We Work With You
    • Values
    • History
  • Team
  • Services
    • Decisions We Inform
    • Forecasting Event
  • Tools
    • PEAK SHARE 360 Suite
      • APEX Tool (beta)
      • SCORE Tool
      • REAL (coming soon)
      • Devil’s Advocate Tool
    • US PRICING Suite
      • US Pricing Tool
      • Gross-to-Net Tool (US)
      • Inflation Reduction Act (IRA) Tool
      • MAPPI Tool
    • Forecasting Support
      • Early-Stage Forecasting Tool (coming soon)
  • Our Work
    • view by Therapy Area
    • view by Our Services
  • How We Work
  • Clients
  • Insights
  • News & Events
  • Careers
  • Contact Us
  • Menu Menu
groupH

About groupH

This author has not written his bio yet.
But we are proud to say that groupH contributed 44 entries already.

Entries by groupH

Real World Pharma – Affordability vs. Cost Effectiveness. Impressions from 18th ISPOR in Milan

1st November 2015/in Comment

Attending ISPOR when keeping your ear to the ground in Market Access matters is non-negotiable. And this year was no exception. Noticeable to us was that many presentations and workshops revolved around two important and related concepts: affordability and uncertainty. Here is some background. Affordability is very different from cost effectiveness. Cost effectiveness is often […]

groupH is now at groupH.com

1st October 2015/in News

We are pleased to announce that the groupH website and all our email addresses have moved over to the web’s most recognised domain name :- .com. With the global scope of our work, moving to groupH.com has long been our aim, and is in line with our ambition to grow groupH not only in Europe, […]

The payers’ perspective on gene therapies: groupH details its study in Nature Biotechnology

10th September 2015/in White Papers

Market Access, and with it Pricing & Reimbursement models, has become an integral part of opportunity assessments for novel drugs and therapies. Nicolas Touchot, head of groupH’s Market Access practice, has looked into the feasibility and desirability of a number of reimbursement frameworks for gene therapies and potential other novel premium priced future therapies. Below […]

groupH’s first family day picnic – a good time was had by all!

1st September 2015/in News

One sunny autumnal day in September, a group of us convened for groupH’s first family day picnic in the beautiful surroundings of Greenwich Park, London. As a virtual company, it was lovely to catch up with colleagues and other halves, and finally meet the (not-so) new additions to the families. Surrounded by buggies, bikes, kids and dogs, […]

Silver Opti Regatta 2015

10th June 2015/in News

groupH is pleased to be one of the companies that sponsor an annual sailing Regatta for children in Germany. The races are held in June each year at a small club based on the shores of Tegernsee, one of the mountain lakes outside of Munich. One of Yacht-Club am Tegernsee’s main objectives is to promote […]

Experience the new Reading Room at the Wellcome Collection

1st June 2015/in News

We’re looking forward to checking out the newly updated Reading Room at the Wellcome Collection in London soon. It promises to be a stimulating space to immerse yourself into; great to visit alone, or to meet with friends or colleagues. Billed as a new kind of participatory space – an innovative blend of gallery, library […]

Turning Ten

1st April 2015/in News

The design work of Michael and Marcelle Lawson-Smith has come to tell the story of groupH over the years from the company’s inception to the present day. To mark our 10 year anniversary, here’s a retrospective of the last decade in their words and pictures… The pause on the other end of the phone line […]

groupH’s strategic Market Access practice reports favourable payer views on novel long-acting injectables

1st March 2015/in White Papers

groupH’s strategic Market Access practice reports favourable payer views on novel long-acting injectables. The Market Access team here at groupH, with permission from MedinCell, recently published a White Paper; revealing in-depth payers’ views on the prospects of value creation through novel long-acting injectables, the challenges associated with evidence generation, and the potential to translate value […]

2014 … a year in 2 min 14 sec

10th December 2014/in News

‘Can I discuss an idea with you perhaps tomorrow? It’s difficult to write this in an e-mail but easier to discuss or brainstorm by phone potentially… are you around?’ Erik had this idea in mind for a different Christmas card this year. ‘Can we show what groupH does through the means of movement and dance? […]

2014 … a year in 2 min 14 sec (Behind-the-scenes commentary)

1st December 2014/in News

‘Can I discuss an idea with you perhaps tomorrow? It’s difficult to write this in an e-mail but easier to discuss or brainstorm by phone potentially… are you around?’ Erik had this idea in mind for a different Christmas card this year. ‘Can we show what groupH does through the means of movement and dance? […]

Page 3 of 512345

Pages

  • Devil’s Advocate Tool
  • Download Form
  • Download270319
  • Gross-to-Net (US) Tool
  • History
  • Home
  • Inflation Reduction Act Tool
  • Peak Share Analogue Tool
  • Peak Share Tool
  • Tools
  • US Pricing Tool
  • About Us
  • Decisions We Inform
  • How We Work With You
  • Therapy Area
  • Service Offering
  • Team
  • Values
  • Forecasting Event
  • Services
  • MAPPI Tool
  • Our Work
  • Clients
  • How We Work
  • Our Insights
  • News & Events
  • Contact us
  • Register
  • Careers
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms & Conditions
  • Training Terms & Conditions

Categories

  • Autoimmune
  • Briefing Note
  • Careers
  • CNS
  • Comment
  • Competitor workshops
  • Demand assessments
  • Dermatology
  • Disease area strategy
  • Events
  • Infectious Disesases
  • Inspiration
  • Interview
  • Market landscaping
  • New Horizons
  • News
  • Oncology
  • Scenario planning workshops
  • Team
  • TPP shaping and validation
  • Uncategorised
  • White Papers

Archive

  • May 2026
  • December 2025
  • August 2025
  • April 2025
  • February 2025
  • December 2024
  • October 2024
  • September 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • June 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • July 2022
  • April 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • January 2021
  • December 2020
  • October 2020
  • June 2020
  • May 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • March 2019
  • December 2018
  • September 2018
  • August 2018
  • May 2018
  • December 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • December 2016
  • November 2016
  • October 2016
  • May 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • June 2015
  • April 2015
  • March 2015
  • December 2014
  • September 2014
  • November 2013
  • July 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • December 2012
  • November 2012
  • September 2012
  • February 2012
  • December 2010

© groupH Ltd

LinkedIn
newsletter
Vimeo

  • Contact us
  • Tools
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Sitemap
Scroll to top Scroll to top Scroll to top
By continuing to use this website you will be agreeing to our Terms & Conditions, our Privacy Policy, and the use of cookies.